Terns Pharmaceuticals (TERN) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.52
-0.43
-0.34
-0.25

Details

Expected EPS
-0.34
Actual EPS
-0.25
Surprise EPS
0.09
Surprise Percent
+26.47%

Description

Terns Pharmaceuticals (TERN) has reported earnings of -0.25 per share for Q2 2023.

0 Comments

Share your thoughts